Compass Health Brands Company Profile

05:31 EST 13th December 2018 | BioPortfolio

Compass Health is Northwest Washington’s behavioral healthcare leader. The organization integrates behavioral health and medical care services to support clients and communities when and where they are needed. Building on a century of experience, Compass Health is forging new, nationally recognized models of care that bring together highly skilled mental health professionals, primary care providers, peer counselors and others to treat the whole person. From comprehensive mental health treatment to crisis intervention, children’s services and community education, Compass Health serves people of all ages throughout Island, San Juan, Skagit, Snohomish and Whatcom counties.

News Articles [472 Associated News Articles listed on BioPortfolio]

Compass’ range

Compass’ multispecific antibody screening and engineering platform allows for efficient library building.

US FDA approves Compass Pathways' phase IIb dose─ranging study in psilocybin therapy for treatment─resistant depression

Compass Pathways, a life sciences company dedicated to accelerating patient access to evidence─based innovation in mental health, has received approval from the US Food and Drug Administration (FDA)...

Compass Pathways Receives FDA Approval for Psilocybin Therapy Clinical Trial for Treatment-resistant Depression

LONDON, August 22, 2018 /PRNewswire/ -- Compass Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health, has received approval from the...

Venture Funding Deals: Alector, Ascentage, Gossamer And Compass Lead Summer Rounds

Compass raises $132m in Series A as it moves from screening to the clinic, and start-up HotSpot Therapeutics comes out...    

FDA grants breakthrough status to COMPASS' depression therapy

The FDA granted breakthrough therapy designation to COMPASS Pathways' psilocybin, which is indicated for treatment-resistant  -More- 

FDA approves Compass' study for treatment-resistant depression drug

The FDA approved a Phase IIb clinical trial for Compass' psilocybin therapy for patients with treatment-resistant depression. -More- 

Compass Therapeutics Closes on Series A Financing Totaling $132 Million

Compass Therapeutics closed on the final $49 million of its $132 million Series A financing. The funds raised will be used to push their lead product, CTX-471 into the clinic as well as to identify tw...

China watchdog probes unit of catering giant Compass over expired school food

Chinese authorities are probing a local unit of global catering giant Compass Group Plc over mouldy and expired food found at a private school served by the group and said it would inspect other schoo...

Drugs and Medications [371 Associated Drugs and Medications listed on BioPortfolio]

Healthy accents triple antibiotic [DZA Brands LLC]

DZA Brands, LLC Triple Antibiotic Ointment Drug Facts

Healthy accents allergy relief [DZA Brands LLC]

DZA Brands, LLC Allergy Relief Drug Facts

Healthy accents clear lax [DZA Brands LLC]

DZA Brands, LLC ClearLax® Drug Facts

Healthy accents hemorrhoidal [DZA Brands LLC]

DZA Brands, LLC Hemorrhoidal Suppositories Drug Facts

Healthy accents sleep aid [DZA Brands LLC]

DZA Brands, LLC Sleep Aid Tablets Drug Facts

PubMed Articles [3577 Associated PubMed Articles listed on BioPortfolio]

Assessments of some metals contamination in lipsticks and their associated health risks to lipstick consumers in Iran.

In this study, the concentrations of lead, cadmium, and chromium in lipstick samples were evaluated. The samples were from different brands and produced in different countries. The average lead, cadmi...

The neural correlates of trustworthiness evaluation of faces and brands: Implications for behavioral and consumer neuroscience.

When we buy a product of a brand, we trust the brand to provide good quality and reliability. Therefore, trust plays a major role in consumer behavior. It is unclear, however, how trust in brands is p...

Guiding COMPASS: Dpy-30 Positions SET1/MLL Epigenetic Signaling.

In this issue of Structure, Haddad et al. (2018) solve the high-resolution trimeric crystal structure of human COMPASS-like components Dpy-30 and Ash2L (2:1) to unravel an uncharacterized interaction...

A comparison between the Compass fundus perimeter and the Humphrey Field Analyzer.

To evaluate relative diagnostic precision and test retest variability of two devices, the Compass (CMP, CenterVue, Italy) fundus perimeter and the Humphrey Field Analyzer (HFA, Zeiss, Dublin), in dete...

Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts.

Expression of Runx2/p57 is a hallmark of the osteoblast-lineage identity. Although several regulators that control the expression of Runx2/p57 during osteoblast-lineage commitment have been identified...

Clinical Trials [3168 Associated Clinical Trials listed on BioPortfolio]

Compass Course: Efficacy Study

The Compass Course is an 8-session progressive structure that was developed based on theoretical and scientific evidence from psychology and occupational therapy. The goal of the intervent...

A Study to Assess Long-Term Safety of the Transcend CyPass Micro-Stent in Patients Completing the COMPASS Trial

This is an observational study involving patients who completed the COMPASS Trial, in which the Transcend Medical CyPass Micro-Stent was evaluated through 2 years postoperatively . In the ...

Compass Hinge Stabilization of Knee Dislocations: A Randomized Trial

The purpose of this project is to evaluate the effect of the Compass™ Universal Hinge external fixator on the outcome of patients following acute dislocation of the knee

COMPASS-HF Extension Phase

The purpose of the Extension Phase of the COMPASS-HF study is to continue to observe the safety of the Chronicle® Implantable Hemodynamic Monitor (IHM) system and provide study doctors co...

Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study

Cost and Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS),is a cohort study which aims to capture health care utilization, cost, and quality of life indicators...

Companies [2613 Associated Companies listed on BioPortfolio]

Compass Health Brands

Compass Health is Northwest Washington’s behavioral healthcare leader. The organization integrates behavioral health and medical care services to support clients and communit...

Compass Professional Health Services

Compass Professional Health Services is the champion for simpler, smarter healthcare. At a time when companies are shifting more costs to employees through higher deductibles and ...

Compass Therapeutics

Compass Therapeutics currently has over 15 antibody, antibody combination and bispecific programs advancing through preclinical development, targeting multiple pathways of signifi...

Compass Surgical Partners

Compass Surgical Partners specializes in the management, acquisition and development of ambulatory surgery centers (ASCs) through application of operational discipline and ...

Compass Group

Based in Charlotte NC, Compass Group North America is the leading foodservice and support services company with $9.2 billion in revenues in 2009. With 386,000 associates worldwide, its parent company,...

More Information about "Compass Health Brands" on BioPortfolio

We have published hundreds of Compass Health Brands news stories on BioPortfolio along with dozens of Compass Health Brands Clinical Trials and PubMed Articles about Compass Health Brands for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Compass Health Brands Companies in our database. You can also find out about relevant Compass Health Brands Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record